These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 2682898)

  • 1. De-Nol in the treatment of reflux esophagitis.
    Balan G; Săndulescu E; Cijevschi C; Stanciu R; Darwish R; Stanciu C
    Rev Med Chir Soc Med Nat Iasi; 1989; 93(1):67-70. PubMed ID: 2682898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Colloidal bismuth subcitrate tablets and placebo in chronic duodenal ulceration: a double-blind, randomised trial.
    Wilson P; Alp MH
    Med J Aust; 1982 Mar; 1(5):222-3. PubMed ID: 7045603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A controlled clinical trial with De-Nol (tripotassium dicitrato bismuthate) in patients with gastric ulcer.
    Patty I; Deák G; Jávor T; Mózsik G; Nagy L; Tárnok F
    Int J Tissue React; 1983; 5(4):397-401. PubMed ID: 6368445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cisapride versus ranitidine in the treatment of reflux esophagitis.
    Janisch HD; Hüttemann W; Bouzo MH
    Hepatogastroenterology; 1988 Jun; 35(3):125-7. PubMed ID: 3042576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Assessment of the efficacy of de-nol and bismuth subnitrate treatment of patients with associated peptic ulcer and pyloric Helicobacter infection (experimental and clinical studies)].
    Il'chenko AA; Zurabishvili NG; Zhukhovitskiĭ BG; Gorodinskaia VS
    Ter Arkh; 1991; 63(2):21-6. PubMed ID: 2048016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cimetidine treatment of reflux esophagitis: results of a double-blind study].
    Sonnenberg A; Lepsien G; Berges W; Weber KB; Wienbeck M; Siewert JR; Blum AL
    Schweiz Med Wochenschr; 1979 Apr; 109(16):613-5. PubMed ID: 373103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A double-blind endoscopic study with De-Nol tablets and cimetidine for duodenal ulcer.
    Bianchi Porro G; Petrillo M; De Nicola C; Lazzaroni M
    Scand J Gastroenterol; 1984 Oct; 19(7):905-8. PubMed ID: 6397848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ranitidine therapy for gastroesophageal reflux disease. Results of a large double-blind trial.
    Sontag S; Robinson M; McCallum RW; Barwick KW; Nardi R
    Arch Intern Med; 1987 Aug; 147(8):1485-91. PubMed ID: 3307670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The use of bismuth tripotassium dicitrate (De-Nol), a promising line of pathogenetic therapy for irritated bowel syndrome with diarrhea].
    Iakovenko EP; Agafonova NA; Pokhal'skaia OIu; Kolganova AV; Nazarbekova RS; Ivanov AN; Davletshina IV; Popova EV; Prianishnikova AS; Ovchinnikova NI; Iakovenko AV; Aldiiarova MA; D'iachkoava AV; Gioeva IZ
    Klin Med (Mosk); 2008; 86(10):47-52. PubMed ID: 19069460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [De-nol in NSAID-induced gastroduodenal lesions].
    Cataldo MG; D'Aiuto A; Bongiorno A
    Minerva Dietol Gastroenterol; 1990; 36(1):27-30. PubMed ID: 2186304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short-term treatment of reflux oesophagitis with ranitidine 300 mg nocte. Italian multicentre study.
    Bovero E; Cheli R; Barbara L; Baldi F; Boero A; Mura GC; Camarri E; Corradini P; Dobrilla G; Piazzi L
    Hepatogastroenterology; 1987 Aug; 34(4):155-9. PubMed ID: 3311954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of reflux oesophagitis. A randomized, controlled evaluation of cimetidine.
    Breen KJ; Desmond PV; Whelan G
    Med J Aust; 1983 Nov; 2(11):555-8. PubMed ID: 6355792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of Campylobacter pylori gastritis: a pilot study using pirenzepine dihydrochloride (Gastrozepin) and three formulations of colloidal bismuth subcitrate (De-Nol).
    Morris A; Brown P; Ali MR; Lane M; Palmer R
    N Z Med J; 1988 Oct; 101(856 Pt 1):651-4. PubMed ID: 3054641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparative dynamic study of the effectiveness of gastric cytoprotection by vitamin A, De-Nol, sucralfate and ulcer healing by pirenzepine in patients with chronic gastric ulcer (a multiclinical and randomized study).
    Patty I; Tárnok F; Simon L; Jávor T; Deák G; Benedek S; Kenéz P; Nagy L; Mózsik G
    Acta Physiol Hung; 1984; 64(3-4):379-84. PubMed ID: 6397969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cimetidine and ranitidine in the treatment of reflux esophagitis].
    Kimmig JM
    Z Gastroenterol; 1984 Aug; 22(8):373-8. PubMed ID: 6091353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Omeprazole (20 mg daily) compared to ranitidine (150 mg twice daily) in the treatment of esophagitis caused by reflux. Results of a double-blind randomized multicenter trial in France and Belgium].
    Zeitoun P; Rampal P; Barbier P; Isal JP; Eriksson S; Carlsson R
    Gastroenterol Clin Biol; 1989 May; 13(5):457-62. PubMed ID: 2666237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Double blind randomised study of tripotassium-di-citrato-bismuthate in the treatment of peptic ulcer.
    Tripathi BM; Misra NP; Dube S
    J Assoc Physicians India; 1984 Nov; 32(11):964-5. PubMed ID: 6396295
    [No Abstract]   [Full Text] [Related]  

  • 18. Sucralfate maintenance therapy in reflux esophagitis. Sucralfate Investigational Working Team.
    Tytgat GN; Koelz HR; Vosmaer GD
    Am J Gastroenterol; 1995 Aug; 90(8):1233-7. PubMed ID: 7639221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral cimetidine in reflux esophagitis: a double blind controlled trial.
    Wesdorp E; Bartelsman J; Pape K; Dekker W; Tytgat GN
    Gastroenterology; 1978 May; 74(5 Pt 1):821-4. PubMed ID: 346430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bismuth subsalicylate in the treatment of chronic diarrhea of childhood.
    Gryboski JD; Hillemeier AC; Grill B; Kocoshis S
    Am J Gastroenterol; 1985 Nov; 80(11):871-6. PubMed ID: 3901731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.